• Home
  • About Us
  • Contact
  • Your Account
  • Subscribe
No Result
View All Result
Monday, January 30, 2023
Alternatives Watch
  • Hedge Funds
    • Manager News
    • Mandates
    • Service Provider News
    • CTAs/Managed Futures
  • Private Equity
    • Manager News
    • Mandates
    • Service Provider News
  • Private Credit
    • Manager News
    • Mandates
    • Service Provider News
  • RE/Infrastructure
    • Manager News
    • Mandates
    • Service Provider News
  • Investor News
    • Endowments and Foundations
    • ESG
    • Pensions
    • Platforms
    • Consultants
  • Research
    • Investor Scorecard
    • Manager Scorecard
  • Subscribe
  • Log In
  • Hedge Funds
    • Manager News
    • Mandates
    • Service Provider News
    • CTAs/Managed Futures
  • Private Equity
    • Manager News
    • Mandates
    • Service Provider News
  • Private Credit
    • Manager News
    • Mandates
    • Service Provider News
  • RE/Infrastructure
    • Manager News
    • Mandates
    • Service Provider News
  • Investor News
    • Endowments and Foundations
    • ESG
    • Pensions
    • Platforms
    • Consultants
  • Research
    • Investor Scorecard
    • Manager Scorecard
  • Subscribe
  • Log In
No Result
View All Result
Alternatives Watch
No Result
View All Result

Oberland raises over $1bn for healthcare royalty and credit strategy

Susan BarretobySusan Barreto
October 24, 2022
in Manager News, Private Credit
Oberland raises over $1bn for healthcare royalty and credit strategy

By imagesourcecurated/Envato Elements

ShareTweetShareSendSend

Oberland Capital Management closed its third fund centered on healthcare innovation, with $1.2 billion in investor commitments following six months of fundraising.

Oberland Capital Healthcare Fund III is a royalty and credit fund that offers attractive, non-dilutive sources of capital to leading biotechnology and pharmaceutical companies, research institutions and inventors, said Jean-Pierre Naegeli, managing partner at Oberland Capital in New York.

One of the fund’s investors was the Texas Municipal Retirement System, which placed $110 million in the main fund and another $55 million in co-investment structure.

“We greatly appreciate the strong support from both existing and new investors and their confidence in Oberland Capital’s specialized healthcare investment strategy focused on innovative therapeutics, diagnostics and medical devices that play an important role in the treatment paradigm for serious diseases,” said Oberland Managing Partner Andrew Rubinstein in a statement.

Naegeli and Rubenstein worked together at healthcare royalty firm Paul Capital before forming Oberland in 2013. Prior to working in investments Naegeli spent a decade at Johnson & Johnson and Rubenstein was the CEO of Microban International.

Oberland assets under management are now in excess of $3 billion.

Oberland Capital Management closed its third fund centered on healthcare innovation, with $1.2 billion in investor commitments following six months of fundraising.

Oberland Capital Healthcare Fund III is a royalty and credit fund that offers attractive, non-dilutive sources of capital to leading biotechnology and pharmaceutical companies, research institutions and inventors, said Jean-Pierre Naegeli, managing partner at Oberland Capital in New York.

On of the fund’s investors was the Texas Municipal Retirement System, which placed $110 million in the main fund and another $55 million in co-investment structure.

“We greatly appreciate the strong support from both existing and new investors and their confidence in Oberland Capital’s specialized healthcare investment strategy focused on innovative therapeutics, diagnostics and medical devices that play an important role in the treatment paradigm for serious diseases,” said Oberland Managing Partner Andrew Rubinstein in a statement.

Naegeli and Rubenstein worked together at healthcare royalty firm Paul Capital before forming Oberland in 2013. Prior to working in investments Naegeli spent a decade at Johnson & Johnson and Rubenstein was the CEO of Microban International.

Oberland assets under management are now in excess of $3 billion.

ShareTweetShareSendSend
Previous Post

Chicago’s bravest seeking MWDBE PE fund

Next Post

ESG insights sought amid a growing data-driven investment universe

Related Posts

NJ DOI invests with existing alts managers
Pensions

NJ DOI invests with existing alts managers

Vidrio expands Qontigo partnership with portfolio and risk enhancements
Hedge Funds

Vidrio expands Qontigo partnership with portfolio and risk enhancements

By Rawpixel/Envato Elements
Investor News

Nippon Life to invest $1bn add-on to insurer partnership with Blackstone

CPP adds real estate debt fund
Real Estate/Infrastructure

CPP adds real estate debt fund

SLR Capital raises $2.2bn for direct lending
Private Credit

SLR Capital raises $2.2bn for direct lending

Next Post
ESG insights sought amid a growing data-driven investment universe

ESG insights sought amid a growing data-driven investment universe

Log In/Out

Lost your password?

Search the AW Archives

No Result
View All Result

Recent News

Credit deals outpace private equity

Credit deals outpace private equity

Texas fund allocates $90m to private markets, reviews annual plan

Texas fund allocates $90m to private markets, reviews annual plan

Long/short hedge funds struggle as redemptions surge

Long/short hedge funds struggle as redemptions surge

Vision Ridge raises latest sustainable real assets fund

Vision Ridge raises latest sustainable real assets fund

Be an Alts Insider

Sign up for your FREE daily alts news briefing

Subscribe

Subscribe to AW
Alternatives Watch

© 2019-2022, All Rights Reserved  |  BMV Digital

Navigate Site

  • Hedge Funds
  • Private Equity
  • Private Credit
  • RE/Infrastructure
  • Investor News
  • Research
  • Subscribe
  • Log In

Follow Us

No Result
View All Result
  • Hedge Funds
    • Manager News
    • Mandates
    • Service Provider News
    • CTAs/Managed Futures
  • Private Equity
    • Manager News
    • Mandates
    • Service Provider News
  • Private Credit
    • Manager News
    • Mandates
    • Service Provider News
  • RE/Infrastructure
    • Manager News
    • Mandates
    • Service Provider News
  • Investor News
    • Endowments and Foundations
    • ESG
    • Pensions
    • Platforms
    • Consultants
  • Research
    • Investor Scorecard
    • Manager Scorecard
  • Subscribe
  • Log In

© 2019-2022, All Rights Reserved  |  BMV Digital

Be an alts insider

Start your days in the know with our free newsletter

No, I don't want to be an alts insider

Thank

You!

Follow us
on LinkedIn

Lost your password?

Cookie Consent
We do not use cookies on our website other than those that are strictly necessary for the website to function. By clicking “Accept”, you consent to the use of all six strictly necessary cookies.
Do not sell my personal information.
Cookie Settings Accept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Save & Accept
Powered by CookieYes Logo